These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9613145)

  • 1. [Telomere and telomerase in the differentiation of leukemic cell lines].
    Yamada O; Mizoguchi H
    Nihon Rinsho; 1998 May; 56(5):1322-7. PubMed ID: 9613145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change.
    Yamada O; Takanashi M; Ujihara M; Mizoguchi H
    Leuk Res; 1998 Aug; 22(8):711-7. PubMed ID: 9680098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
    Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
    Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.
    Yamada K; Yagihashi A; Yamada M; Asanuma K; Moriai R; Kobayashi D; Tsuji N; Watanabe N
    Anticancer Res; 2002; 22(2B):1315-20. PubMed ID: 12168944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
    Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on induction of leukemic cell apoptosis by antisense oligodeoxynucleotide of human telomerase RNA].
    Xie W; Lin M
    Zhonghua Xue Ye Xue Za Zhi; 2001 May; 22(5):245-8. PubMed ID: 11877080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.
    Januszkiewicz D; Wysoki J; Lewandowski K; Pernak M; Nowicka K; Rembowska J; Nowak J
    Int J Mol Med; 2003 Dec; 12(6):935-8. PubMed ID: 14612969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
    Bestilny LJ; Brown CB; Miura Y; Robertson LD; Riabowol KT
    Cancer Res; 1996 Aug; 56(16):3796-802. PubMed ID: 8706026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere reduction and telomerase inactivation during neuronal cell differentiation.
    Kruk PA; Balajee AS; Rao KS; Bohr VA
    Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
    Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
    Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and telomerase in hematologic neoplasia.
    Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
    Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
    Fujimoto K; Takahashi M
    Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of telomerase modulation in human hematopoietic progenitor cells.
    Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
    Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in vivo in human malignant hematopoietic cells.
    Nilsson P; Mehle C; Remes K; Roos G
    Oncogene; 1994 Oct; 9(10):3043-8. PubMed ID: 8084612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere reduction in hematologic cells.
    Yamada O; Oshimi K; Mizoguchi H
    Int J Hematol; 1993 Apr; 57(2):181-6. PubMed ID: 8494996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.